Prosensa's Unattributed Round

Prosensa raised a round of funding on October 05, 2010. Investors include GlaxoSmithKline.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's Unattributed Round: